Skip to content

John DiPersio, MD, PhD, on the future of blood cancers
Andrew Kuykendall, MD, discusses updated data from the RALLY-MF trial
John Mascarenhas, MD, discusses the phase 3 SENTRY trial
Nicholas Pannunzio, PhD, discusses Ph-like ALL and CRLF2 rearrangement
FDA accepts sBLA for mosunetuzumab and polatuzumab vedotin combo in relapsed or refractory large B-cell lymphoma

Insider Reader Survey

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Susan O’Brien, MD

Cellular Therapy

Susan O’Brien, MD

Leukemia

Susan O’Brien, MD

Lymphoma

Susan O’Brien, MD

Multiple Myeloma

Susan O’Brien, MD

Myelodysplastic Syndromes

Susan O’Brien, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

June 23, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Susan O’Brien, MD

Susan O’Brien, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
1025 Views
2 years ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

Dr. John DiPersio

AACR 2026, Acute Myeloid Leukemia, Myelodysplastic Syndromes, News, Video Interviews

John DiPersio, MD, PhD, on the future of blood cancers

June 23, 2026

ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis, Video Interviews

Andrew Kuykendall, MD, discusses updated data from the RALLY-MF trial

June 23, 2026

ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms, News

John Mascarenhas, MD, discusses the phase 3 SENTRY trial

June 23, 2026

Insider_YT_Feature_Pannunzio_CLFR2_400x400[15]

AACR 2026, Acute Lymphoblastic Leukemia, News, Video Interviews

Nicholas Pannunzio, PhD, discusses Ph-like ALL and CRLF2 rearrangement

June 22, 2026

FDA stamp on white paper

Lymphoma, Aggressive B-Cell Lymphomas, News

FDA accepts sBLA for mosunetuzumab and polatuzumab vedotin combo in relapsed or refractory large B-cell lymphoma

June 22, 2026

China flag

Multiple Myeloma, News

China NMPA approves supplemental application for generic denosumab

June 20, 2026

Top Categories

Cellular Therapy

74

Leukemia

114

Lymphoma

129

Multiple Myeloma

99

Myelodysplastic Syndromes

40

Myeloproliferative Neoplasms

29

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Susan O’Brien, MD

Cellular Therapy

Susan O’Brien, MD

Leukemia

Susan O’Brien, MD

Lymphoma

Susan O’Brien, MD

Multiple Myeloma

Susan O’Brien, MD

Myelodysplastic Syndromes

Susan O’Brien, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Dr. John DiPersio

John DiPersio, MD, PhD, on the future of blood cancers

Andrew Kuykendall, MD, discusses updated data from the RALLY-MF trial

John Mascarenhas, MD, discusses the phase 3 SENTRY trial

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.